Medinet News

Medinet: Financial results briefing materials for the fiscal year ending 2024/9

Nov 28 14:30

Medinet: Convocation materials for the 29th Annual General Meeting of Shareholders for the fiscal year ending 2024/9 (matters not described in issuance documents)

Nov 26 07:00

Medinet: Notice of Convocation of the 29th Annual General Meeting of Shareholders for the fiscal year ending 2024/9

Nov 26 07:00

Medinet: Notice Concerning Election of Director Candidates and Audit & Supervisory Board Candidates

Nov 22 14:30

Medinet: Notice Concerning Decrease in Capital and Capital Reserve Amounts and Disposal of Surplus Funds

Nov 22 14:30

Medinet: Notice regarding the recording of non-operating income and extraordinary losses

Nov 13 14:30

Medinet: Summary of Financial Results 2024

Nov 13 14:30

Medinet: Summary of financial results for the fiscal year ending September 2024 [Japanese GAAP] (unconsolidated)

Nov 13 14:30

Medinet: Explanatory materials on business plans and growth potential

Nov 13 14:30

Medinet: (Changes in disclosure matters) Changes in the use of funds and planned expenditure periods relating to the issuance of stock acquisition rights through third-party allotment

Nov 8 14:30

Medinet: [Progress of disclosure matters] Decision to discontinue development of regenerative medicine products for the purpose of treating chronic heart failure

Nov 8 14:30

Medinet: (Changes in disclosure matters) Changes in the planned expenditure period relating to the issuance of stock acquisition rights through third-party allotment

Sep 27 16:00

Medinet: Notice regarding mass exercise and completion of exercise of the 19th Stock Acquisition Rights (with exercise price amendment clause) through third party allotment

Sep 11 15:00

Medinet: Strategic partnership agreement signed with AGC for cell therapy CDMO business

Sep 11 10:00

Medinet: Notice regarding the monthly exercise status of the 19th Stock Acquisition Rights (with exercise price amendment clause) through third-party allotment

Sep 2 14:00

Medinet: Announcements of individual stocks regarding the recognition of non-operating revenue.

Aug 9 14:00

Medinet: Overview of Q3 2024 financial results.

Aug 9 14:00

Medinet: Third quarter financial report for the September 2024 period (Japanese standard) (non-consolidated)

Aug 9 14:00

Medinet: Started manufacturing outsourcing for a new specified cell processed product ("S-DSC") related to hair regeneration.

Aug 8 14:00

Medinet: (Progress of disclosure matters) **** regulatory authorities have approved the provision of γδT cell therapy at new medical institutions (progress of licensing agreement with Medigen Biotechnology Corp.)

Jul 8 14:00